Mankind Pharma Ltd (MANKIND) - Total Liabilities

Latest as of September 2025: Rs132.85 Billion INR ≈ $1.44 Billion USD

Based on the latest financial reports, Mankind Pharma Ltd (MANKIND) has total liabilities worth Rs132.85 Billion INR (≈ $1.44 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Mankind Pharma Ltd cash conversion from operations to assess how effectively this company generates cash.

Mankind Pharma Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how Mankind Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data. Check MANKIND asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Mankind Pharma Ltd Competitors by Total Liabilities

The table below lists competitors of Mankind Pharma Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Walgreens Boots Alliance Inc NASDAQ:WBA	USA	$62.09 Billion
Stantec Inc TO:STN	Canada	CA$4.72 Billion
Banque Cantonale Vaudoise SW:BCVN	Switzerland	CHF57.64 Billion
Leonardo DRS, Inc. Common Stock NASDAQ:DRS	USA	$1.60 Billion
Subsea 7 S.A. OL:SUBC	Norway	Nkr4.03 Billion
United Spirits Limited NSE:MCDOWELL-N	India	Rs50.76 Billion
Anglo American Platinum Ltd JSE:AMS	South Africa	ZAC68.83 Billion
Grupo Aeroportuario del Pacífico S.A.B. de C.V F:G9N	Germany	€59.56 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Mankind Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Mankind Pharma Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mankind Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mankind Pharma Ltd (2019–2025)

The table below shows the annual total liabilities of Mankind Pharma Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs131.91 Billion ≈ $1.43 Billion	+452.53%
2024-03-31	Rs23.87 Billion ≈ $258.20 Million	+15.52%
2023-03-31	Rs20.67 Billion ≈ $223.50 Million	-27.01%
2022-03-31	Rs28.31 Billion ≈ $306.21 Million	+87.54%
2021-03-31	Rs15.10 Billion ≈ $163.27 Million	+7.71%
2020-03-31	Rs14.02 Billion ≈ $151.59 Million	+23.96%
2019-03-31	Rs11.31 Billion ≈ $122.29 Million	--

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$10.36 Billion

Rs957.50 Billion INR

Market Cap Rank

#2189 Global

#85 in India

Share Price

Rs2319.50

Change (1 day)

+2.73%

52-Week Range

Rs1927.40 - Rs2696.50

All Time High

Rs2998.40